Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Raw Materials: 2019-2025

Historic Raw Materials for Aytu Biopharma (AYTU) over the last 7 years, with Jun 2025 value amounting to $1.1 million.

  • Aytu Biopharma's Raw Materials rose 90.56% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 90.56%. This contributed to the annual value of $1.1 million for FY2025, which is 319.17% up from last year.
  • As of FY2025, Aytu Biopharma's Raw Materials stood at $1.1 million, which was up 319.17% from $266,000 recorded in FY2024.
  • Over the past 5 years, Aytu Biopharma's Raw Materials peaked at $2.3 million during FY2021, and registered a low of $266,000 during FY2024.
  • Over the past 3 years, Aytu Biopharma's median Raw Materials value was $1.1 million (recorded in 2025), while the average stood at $894,000.
  • As far as peak fluctuations go, Aytu Biopharma's Raw Materials surged by 471.54% in 2021, and later crashed by 79.55% in 2024.
  • Aytu Biopharma's Raw Materials (Yearly) stood at $2.3 million in 2021, then declined by 20.05% to $1.8 million in 2022, then declined by 28.28% to $1.3 million in 2023, then crashed by 79.55% to $266,000 in 2024, then soared by 319.17% to $1.1 million in 2025.